CY2006006I2 - Πρωτεϊνικα σκευασματα - Google Patents

Πρωτεϊνικα σκευασματα

Info

Publication number: CY2006006I2
Authority: CY; Cyprus
Prior art keywords: protein formulations; formulations; protein
Prior art date: 1998-04-28

Application number

CY200600006C

Other languages

English (en)

Other versions

CY2006006I1 (el

Original Assignee

Nps Allelix Corporation

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1998-04-28

Filing date

2006-10-23

Publication date

2009-11-04

2006-10-23 Application filed by Nps Allelix Corporation filed Critical Nps Allelix Corporation

2009-11-04 Publication of CY2006006I2 publication Critical patent/CY2006006I2/el

2009-11-04 Publication of CY2006006I1 publication Critical patent/CY2006006I1/el

Links

239000000203 mixture Substances 0.000 title 1
102000004169 proteins and genes Human genes 0.000 title 1
108090000623 proteins and genes Proteins 0.000 title 1

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- A61K38/22—Hormones
- A61K38/29—Parathyroid hormone (parathormone); Parathyroid hormone-related peptides
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
- A61P19/10—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease for osteoporosis

CY200600006C 1998-04-28 2006-10-23 Πρωτεϊνικα σκευασματα CY2006006I1 (el)

Applications Claiming Priority (2)

Application Number	Priority Date	Filing Date	Title
SE9801495A SE9801495D0 (sv)	1998-04-28	1998-04-28	Protein formulationa
PCT/CA1999/000376 WO1999055353A2 (en)	1998-04-28	1999-04-26	Protein formulations

Publications (2)

Publication Number	Publication Date
CY2006006I2 true CY2006006I2 (el)	2009-11-04
CY2006006I1 CY2006006I1 (el)	2009-11-04

Family

ID=20411122

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
CY200600006C CY2006006I1 (el)	1998-04-28	2006-10-23	Πρωτεϊνικα σκευασματα

Country Status (24)

Country	Link
US (1)	US20050209144A1 (el)
EP (1)	EP1079803B1 (el)
JP (2)	JP4733267B2 (el)
KR (1)	KR100579872B1 (el)
CN (1)	CN1172658C (el)
AT (1)	ATE273693T1 (el)
AU (2)	AU766514B2 (el)
BR (1)	BR9909958A (el)
CA (1)	CA2329800C (el)
CY (1)	CY2006006I1 (el)
DE (3)	DE69919533T2 (el)
DK (1)	DK1079803T3 (el)
ES (1)	ES2224637T3 (el)
FR (1)	FR06C0032I2 (el)
HK (1)	HK1041218B (el)
IL (1)	IL139320A (el)
LU (1)	LU91281I2 (el)
NL (1)	NL300243I2 (el)
NZ (1)	NZ508269A (el)
PT (1)	PT1079803E (el)
SE (1)	SE9801495D0 (el)
SI (1)	SI1079803T1 (el)
WO (1)	WO1999055353A2 (el)
ZA (1)	ZA200006040B (el)

Families Citing this family (20)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US6770623B1 (en)	1997-12-09	2004-08-03	Eli Lilly And Company	Stabilized teriparatide solutions
SE9801495D0 (sv) *	1998-04-28	1998-04-28	Astra Ab	Protein formulationa
US20050032698A1 (en) *	2003-07-14	2005-02-10	Nps Allelix Corp.	Stabilized formulation of parathyroid hormone
EP1945245A2 (en) *	2005-11-10	2008-07-23	The Board of Control of Michigan Technological University	Black bear parathyroid hormone and methods of using black bear parathyroid hormone
US7803770B2 (en)	2006-10-03	2010-09-28	Radius Health, Inc.	Method of treating osteoporosis comprising administration of PTHrP analog
USRE49444E1 (en)	2006-10-03	2023-03-07	Radius Health, Inc.	Method of treating osteoporosis comprising administration of PTHrP analog
BRPI0719821B8 (pt)	2006-10-03	2021-05-25	Ipsen Pharma Sas	composição estável na armazenagem apropriada para administração a pacientes
FR2925333B1 (fr) *	2007-12-19	2012-04-13	Farid Bennis	Compositions pharmaceutiques renfermant au moins un principe actif proteinique protege des enzymes digestives
JP2009091363A (ja) *	2008-11-21	2009-04-30	Asahi Kasei Pharma Kk	Ｐｔｈの安定化水溶液注射剤
AU2009356227A1 (en)	2009-12-07	2012-06-21	Michigan Technological University	Black bear parathyroid hormone and methods of using black bear parathyroid hormone
CN104645318B (zh) *	2011-06-07	2021-11-02	旭化成制药株式会社	高纯度含pth冷冻干燥制剂及其制造方法
CN103301058A (zh) *	2013-06-17	2013-09-18	深圳翰宇药业股份有限公司	一种特立帕肽注射用组合物及其制备方法和制剂
IL307981A (en)	2015-04-29	2023-12-01	Radius Pharmaceuticals Inc	Cancer treatment methods
CN106309358A (zh) *	2015-06-29	2017-01-11	成都金凯生物技术有限公司	含有人甲状旁腺激素的药物组合物及其制备方法与用途
JP7481115B2 (ja)	2017-01-05	2024-05-10	ラジウスファーマシューティカルズ，インコーポレイテッド	Ｒａｄ１９０１－２ｈｃｌの多形性形態
CN108333360A (zh) *	2017-01-19	2018-07-27	深圳市新产业生物医学工程股份有限公司	胃泌素释放肽前体稀释液及其应用和试剂盒
US10996208B2 (en)	2017-04-28	2021-05-04	Radius Health, Inc.	Abaloparatide formulations and methods of testing, storing, modifying, and using same
EP3685849A4 (en) *	2017-09-22	2021-12-22	Asahi Kasei Pharma Corporation	LIQUID PHARMACEUTICAL COMPOSITION CONTAINING TRIPARATIDE WITH EXCELLENT STABILITY
CN108159404B (zh) *	2018-01-05	2019-08-27	北京博康健基因科技有限公司	重组人甲状旁腺激素制剂及其制备方法
SG11202013177WA (en)	2018-07-04	2021-01-28	Radius Pharmaceuticals Inc	Polymorphic forms of rad 1901-2hcl

Family Cites Families (14)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US5981485A (en) *	1997-07-14	1999-11-09	Genentech, Inc.	Human growth hormone aqueous formulation
DE3935738A1 (de) *	1989-10-27	1991-05-08	Forssmann Wolf Georg	Arzneimittel, enthaltend das humane parathormon-fragment (1-37) als aktiven wirkstoff
US5744444A (en) *	1989-10-27	1998-04-28	Haemopep Pharma Gmbh	HPTH-fragment-(1-37), the preparation thereof, medicaments containing same and the use thereof
US5547939A (en) *	1991-06-14	1996-08-20	The Regents Of The University Of California	Broad spectrum antimicrobial compounds and methods of use
JP2662842B2 (ja) *	1991-12-09	1997-10-15	旭化成工業株式会社	パラサイロイドホルモンの安定化組成物
ES2129048T3 (es) *	1991-12-09	1999-06-01	Asahi Chemical Ind	Composicion estabilizada de hormona paratiroide.
ATE220327T1 (de) *	1992-09-29	2002-07-15	Inhale Therapeutic Syst	Pulmonale abgabe von aktiven fragmenten des parathormons
US5496801A (en) *	1993-12-23	1996-03-05	Allelix Biopharmaceuticals Inc.	Parathyroid hormone formulation
JPH09157294A (ja) *	1995-06-15	1997-06-17	Takeda Chem Ind Ltd	副甲状腺ホルモン誘導体
DE19538687A1 (de) *	1995-10-17	1997-04-24	Boehringer Mannheim Gmbh	Stabile pharmazeutische Darreichungsformen enthaltend Parathormon
JP4053107B2 (ja) *	1996-02-01	2008-02-27	中外製薬株式会社	血小板減少症の予防剤および治療剤
US5964807A (en) *	1996-08-08	1999-10-12	Trustees Of The University Of Pennsylvania	Compositions and methods for intervertebral disc reformation
DE19733651A1 (de) *	1997-08-04	1999-02-18	Boehringer Ingelheim Pharma	Wässrige Aerosolzubereitungen enthaltend biologisch aktive Markomoleküle und Verfahren zur Erzeugung entsprechender Aerosole
SE9801495D0 (sv) *	1998-04-28	1998-04-28	Astra Ab	Protein formulationa

1998
- 1998-04-28 SE SE9801495A patent/SE9801495D0/xx unknown
1999
- 1999-04-26 WO PCT/CA1999/000376 patent/WO1999055353A2/en active IP Right Grant
- 1999-04-26 DE DE69919533T patent/DE69919533T2/de not_active Expired - Lifetime
- 1999-04-26 EP EP99917715A patent/EP1079803B1/en not_active Expired - Lifetime
- 1999-04-26 DK DK99917715T patent/DK1079803T3/da active
- 1999-04-26 ES ES99917715T patent/ES2224637T3/es not_active Expired - Lifetime
- 1999-04-26 AT AT99917715T patent/ATE273693T1/de active
- 1999-04-26 CN CNB998073628A patent/CN1172658C/zh not_active Expired - Lifetime
- 1999-04-26 PT PT99917715T patent/PT1079803E/pt unknown
- 1999-04-26 AU AU35916/99A patent/AU766514B2/en not_active Expired
- 1999-04-26 BR BR9909958-6A patent/BR9909958A/pt not_active Application Discontinuation
- 1999-04-26 DE DE122006000057C patent/DE122006000057I2/de active Active
- 1999-04-26 KR KR1020007012037A patent/KR100579872B1/ko not_active IP Right Cessation
- 1999-04-26 SI SI9930678T patent/SI1079803T1/xx unknown
- 1999-04-26 IL IL139320A patent/IL139320A/en not_active IP Right Cessation
- 1999-04-26 DE DE1999619533 patent/DE122006000057I1/de active Pending
- 1999-04-26 CA CA002329800A patent/CA2329800C/en not_active Expired - Lifetime
- 1999-04-26 JP JP2000545551A patent/JP4733267B2/ja not_active Expired - Lifetime
- 1999-04-26 NZ NZ508269A patent/NZ508269A/en not_active IP Right Cessation
2000
- 2000-10-26 ZA ZA200006040A patent/ZA200006040B/en unknown
2002
- 2002-04-19 HK HK02102980.6A patent/HK1041218B/zh not_active IP Right Cessation
2004
- 2004-01-16 AU AU2004200156A patent/AU2004200156B2/en not_active Expired
- 2004-11-30 US US10/999,160 patent/US20050209144A1/en not_active Abandoned
2006
- 2006-10-17 NL NL300243C patent/NL300243I2/nl unknown
- 2006-10-19 LU LU91281C patent/LU91281I2/fr unknown
- 2006-10-20 FR FR06C0032C patent/FR06C0032I2/fr active Active
- 2006-10-23 CY CY200600006C patent/CY2006006I1/el unknown
2011
- 2011-01-24 JP JP2011011811A patent/JP5753692B2/ja not_active Expired - Lifetime

Also Published As

Publication number	Publication date
DE69919533T2 (de)	2005-09-08
NL300243I1 (nl)	2006-12-01
AU766514B2 (en)	2003-10-16
ZA200006040B (en)	2002-01-28
AU2004200156A1 (en)	2004-02-12
SE9801495D0 (sv)	1998-04-28
FR06C0032I2 (fr)	2007-04-27
CN1319003A (zh)	2001-10-24
DE69919533D1 (de)	2004-09-23
HK1041218B (zh)	2005-03-18
KR20010052276A (ko)	2001-06-25
CA2329800A1 (en)	1999-11-04
JP4733267B2 (ja)	2011-07-27
CN1172658C (zh)	2004-10-27
DE122006000057I1 (de)	2007-01-04
JP2002512973A (ja)	2002-05-08
CA2329800C (en)	2004-06-15
JP2011105739A (ja)	2011-06-02
ES2224637T3 (es)	2005-03-01
CY2006006I1 (el)	2009-11-04
KR100579872B1 (ko)	2006-05-12
DK1079803T3 (da)	2004-11-22
IL139320A0 (en)	2001-11-25
IL139320A (en)	2007-06-17
EP1079803B1 (en)	2004-08-18
EP1079803A2 (en)	2001-03-07
JP5753692B2 (ja)	2015-07-22
US20050209144A1 (en)	2005-09-22
AU3591699A (en)	1999-11-16
WO1999055353A3 (en)	2000-01-13
SI1079803T1 (en)	2005-02-28
FR06C0032I1 (el)	2006-11-24
ATE273693T1 (de)	2004-09-15
HK1041218A1 (en)	2002-07-05
BR9909958A (pt)	2000-12-26
LU91281I2 (fr)	2006-12-19
AU2004200156B2 (en)	2005-12-15
NZ508269A (en)	2003-12-19
WO1999055353A2 (en)	1999-11-04
DE122006000057I2 (de)	2009-11-05
PT1079803E (pt)	2004-11-30
NL300243I2 (nl)	2007-02-01

Publication	Publication Date	Title
CY2006006I1 (el)	2009-11-04	Πρωτεϊνικα σκευασματα
IS5555A (is)	2000-06-30	Selekoxib lyfjablöndur
ID30031A (id)	2001-11-01	Formulasi-formulasi agrokimia
ID23546A (id)	2000-05-04	Formulasi-formulasi ziprasidon
NO20004240L (no)	2000-10-18	Formuleringer
ATE224703T1 (de)	2002-10-15	Brauseformulierungen
ATE285788T1 (de)	2005-01-15	Aktiviertes protein c formulierungen
PT1130966E (pt)	2005-04-29	Formulacoes antiparasitarias
MA24473A1 (fr)	1998-10-01	Formulations
NO992339L (no)	1999-11-16	Farmasöytiske formuleringer
EP1113799A4 (en)	2004-06-09	PROTEIN-BASED PREPARATION
IS2325B (is)	2007-12-15	Örgerðar samsetningar epleróns
NO982097D0 (no)	1998-05-08	Peptider
NO982098D0 (no)	1998-05-08	Peptider
ID29635A (id)	2001-09-06	Formulasi mikrokapsul
ATE260674T1 (de)	2004-03-15	Stabilisierte proteinzusammensetzung
ATE357237T1 (de)	2007-04-15	Formulierungen enthaltend cefuroxim-axetil
ID27655A (id)	2001-04-19	Formulasi mikrokapsul
ATE217021T1 (de)	2002-05-15	Präparationsmittel
ATE246494T1 (de)	2003-08-15	Brausezubereitungen
ATE295417T1 (de)	2005-05-15	Angiostatin-bindendes protein
DK0862850T3 (da)	2003-08-25	Mejetærsker
ID23663A (id)	2000-05-11	Persiapan kaprolaktam
DK1088069T3 (da)	2005-09-05	Angiostatin-bindende protein
SE9802189D0 (sv)	1998-06-18	New Proteins